SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-020614
Filing Date
2023-04-26
Accepted
2023-04-26 16:39:21
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-26

Document Format Files

Seq Description Document Type Size
1 ARS edge20008374x3_ars.pdf ARS 2294977
  Complete submission text file 0001140361-23-020614.txt   3160457
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36183 | Film No.: 23850377
SIC: 2836 Biological Products, (No Diagnostic Substances)